Event
Cytokinetics Inc (CYTK)
Cytokinetics Announces Presentation at the Virtual 33rd International Symposium on ALS/MND
Business News
Johnson & Johnson (JNJ)
Johnson & Johnson - RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung …
SEC News
Sarepta Therapeutics Inc (SRPT)
Rodino-Klapac Louise 🟢 acquired 143.9K shares of Sarepta Therapeutics, Inc. (SRPT) Transaction Date: Sep 03, 2025 | Filing ID: 197425
About Us
The main activity of our team is the prompt receipt of open information from various sources in order to analyze the market reaction to this information.
Our strategies:
- a combination of various open sources of information with the identification and use of those that provide information most quickly;
- extracting information mainly by automatic means using artificial intelligence;
- providing users with structured information with modern available development tools;
- the use of approaches and tools of machine learning methods to identify the most important events that affect the market;